Synergistic Induction of Apoptosis by Quercetin and Curcumin in Chronic Myeloid Leukemia (K562) Cells

References

• Koca E and Haznedaroglu IC: Imatinib mesylate and the management of chronic myeloid leukemia (CML). Turk J Hematol 22, 161–172, 2005.
   PubMedGoogle Scholar
• Maekawa T, Ashihara E, and Kimura S: The BCR-ABL tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias. Int J Clin Oncol 12, 327–340, 2007.
   PubMed Web of Science ®Google Scholar
• Mauro MJ: Defining and managing imatinib resistance. ASH Education Book 1, 219–225, 2006.
   Google Scholar
• Santos FP and Ravandi F: Advances in treatment of chronic myelogenous leukemia new treatment options with tyrosine kinase inhibitors. Leuk Lymphoma 2, 16–26, 2009.
   Web of Science ®Google Scholar
• Asensi M, Ortega A, Mena S, Feddi F, and Estrela JM: Natural polyphenols in cancer therapy. Crit Rev Clin Lab Sci 48, 197–216, 2011.
   PubMed Web of Science ®Google Scholar
• Middleton Jr. E, Kandaswami C, and Theoharides TC: The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 4, 673–751, 2000.
   Google Scholar
• Formica JV and Regelson W: Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 12, 1061–1080, 1995.
   Web of Science ®Google Scholar
• Marzocchella L, Fantini M, Benvenuto M, Masuelli L, Tresoldi I, et al.: Dietary flavonoids: molecular mechanisms of action as anti-inflammatory agents. Recent Pat Inflamm Allergy Drug Discov 5, 200–220, 2011.
   PubMedGoogle Scholar
• Hakkinen SH, Karenlampi SO, Heinonen IM, Mykkanen HM, and Torronen AR: Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agric Food Chem 6, 2274–2279, 1999.
   Web of Science ®Google Scholar
• Welton AF, Hurley J, and Will P: Flavonoids and arachidonic acid metabolism. Prog Clin Biol Res 280, 301–312, 1988.
   PubMedGoogle Scholar
• Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, et al.: Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med 2011: article ID 591356, 15 pages, 2011. doi:10.1093/ecam/neq053
   PubMed Web of Science ®Google Scholar
• Fantini M, Benvenuto M, Masuelli L, Frajese GV, Tresoldi I, et al.: In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. Int J Mol Sci 16, 9236–9282, 2015.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Kısmalı G, and Aggarwal BB: Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 1, 2–13, 2013.
   Web of Science ®Google Scholar
• Salem M, Rohani S, and Gillies ER: Curcumin, a promising anti-cancer therapeutic: a review of its chemical properties, bioactivity and approaches to cancer cell delivery. RSC Adv 4, 10815–10829, 2014.
   Web of Science ®Google Scholar
• Wu LX, Wu Y, Chen RJ, Liu Y, Huang LS, et al.: Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro. Acta Pharmacol Sinica 35, 401–409, 2014.
   PubMed Web of Science ®Google Scholar
• Taverna S, Giallombardo M, Pucci M, Flugy A, Manno M, et al.: Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21. Oncotarget 6, 21918–21933, 2015.
   PubMed Web of Science ®Google Scholar
• Jia YL, Li J, Qin ZH, and Liang ZQ: Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J Asian Nat Prod Res 11, 918–928, 2016.
   Web of Science ®Google Scholar
• Kim HG, Lee JH, Lee SJ, Oh JH, Shin E, et al.: The increased cellular uptake and biliary excretion of curcumin by quercetin: a possible role of albumin binding interaction. Drug Metab Dispos 40, 1452–1455, 2012.
   PubMed Web of Science ®Google Scholar
• Altundag EM, Kasaci T, Yilmaz AM, Karademir B, Koçtürk S, et al.: Quercetin-induced cell death in human papillary thyroid cancer (B-CPAP) cells. J Thyroid Res 2016: article ID 9843675, 10 pages, 2016. doi:10.1155/2016/9843675
   Web of Science ®Google Scholar
• Altundag EM, Yilmaz AM, Corek C, Yalcin AS, Taga Y, et al.: Synergistic effects of methotrexate and suberoylanilide hydroxamic acid in triggering apoptosis of chronic myeloid leukemia cells. Int J Hem Onc 25, 1–10, 2015.
   Google Scholar
• Mertens-Talcott SU, Talcott ST, and Percival SS: Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J Nutr 133, 2669–2774, 2003.
   PubMed Web of Science ®Google Scholar
• Chou TC and Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22, 27–55, 1984.
   PubMedGoogle Scholar
• Chang HS, Huang HC, Huang TC, Yang PC, Wang YC, et al.: Flow cytometric detection of reactive oxygen species. Bio-protocol 3, 1–3, 2013.
   Google Scholar
• Sebastià J, Cristòfol R, Martín M, Rodríguez-Farré E, and Sanfeliu. C: Evaluation of fluorescent dyes for measuring intracellular glutathione content in primary cultures of human neurons and neuroblastoma SH-SY5Y. Cytometry A 51, 16–25, 2003.
   PubMed Web of Science ®Google Scholar
• Guomin N, Songmei Y, Shuangfeng X, Yiqing L, Danian N, et al.: Quercetin induces apoptosis by activating caspase-3 and regulating Bcl-2 and cyclooxygenase-2 pathways in human HL-60 cells. Acta Biochim Biophys Sin 43, 30–37, 2011.
   Google Scholar
• Chou TC: Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58, 621–681, 2006.
   PubMed Web of Science ®Google Scholar
• Nebbioso A, Carafa V, Benedetti R, and Altucci L: Trials with ‘epigenetic’ drugs: an update. Molecular Oncol 6, 657–682, 2012.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Call TG, Zent CS, Leis JF, LaPlant B, et al.: Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer 119, 363–370, 2013.
   PubMed Web of Science ®Google Scholar
• Khan HY, Zubair H, Ullah MF, Ahmad A, and Hadi SM: A pro-oxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols. Current Drug Targets 13, 1738–1749, 2012.
   PubMed Web of Science ®Google Scholar
• Pelicano H, Carney D, and Huang P: ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7, 97–110, 2004.
   PubMed Web of Science ®Google Scholar
• Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, et al.: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489, 1997.
   PubMed Web of Science ®Google Scholar
• Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35, 495–516, 2007.
   PubMed Web of Science ®Google Scholar
• Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, et al.: Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ 9, 252–263, 2002.
   PubMed Web of Science ®Google Scholar
• Grimm S and Brdiczka D: The permeability transition pore in cell death. Apoptosis 12, 841–855, 2007.
   PubMed Web of Science ®Google Scholar
• Li Y, He K, Huang Y, Zheng D, Gao C, et al.: Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells. Mol Carcinog 49, 630–640, 2010.
   PubMed Web of Science ®Google Scholar
• Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, et al.: Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. J Biol Chem 274, 22932–22940, 1999.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Lin MT, Zhou MJ, Yi T, Tangy YN, et al.: Combinational treatment of curcumin and quercetin against gastric cancer MGC-803 cells in vitro. Molecules 20, 11524–11534, 2015.
   PubMed Web of Science ®Google Scholar
• Teiten MH, Gaascht F, Dicato M, and Diederich M: Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents. Curr Pharm Biotechnol 13, 245–254, 2012.
   PubMed Web of Science ®Google Scholar